Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DFMO Chemoprevention of Skin Cancer in Organ Transplant Recipients
NCT00204789Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Jul 2003
- Primary completion
- Dec 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of eflornithine in skin cancer, sponsored by University of Wisconsin–Madison. Started Jul 2003; status: completed.
02
Drugs
eflornithine
03
Conditions
skin cancer
Beyond the preview
Go deeper on NCT00204789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00204789.